Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 13 studies | 25% ± 8% | |
intestine | 11 studies | 33% ± 22% | |
kidney | 6 studies | 31% ± 12% | |
prostate | 5 studies | 22% ± 4% | |
pancreas | 4 studies | 24% ± 2% | |
uterus | 4 studies | 26% ± 7% | |
skin | 4 studies | 25% ± 7% | |
eye | 3 studies | 24% ± 2% | |
adrenal gland | 3 studies | 27% ± 5% | |
lymph node | 3 studies | 23% ± 3% | |
breast | 3 studies | 33% ± 7% | |
liver | 3 studies | 36% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 99% | 8109.46 | 644 / 653 | 84% | 303.80 | 507 / 605 |
pancreas | 86% | 5903.76 | 282 / 328 | 95% | 177.92 | 169 / 178 |
brain | 90% | 4586.39 | 2383 / 2642 | 90% | 171.46 | 632 / 705 |
prostate | 85% | 5101.36 | 209 / 245 | 81% | 252.28 | 408 / 502 |
stomach | 98% | 8267.36 | 351 / 359 | 65% | 107.36 | 186 / 286 |
breast | 95% | 5138.00 | 435 / 459 | 65% | 98.21 | 723 / 1118 |
liver | 99% | 17885.83 | 224 / 226 | 59% | 280.21 | 240 / 406 |
lung | 88% | 4584.03 | 508 / 578 | 67% | 105.40 | 772 / 1155 |
kidney | 94% | 8260.70 | 84 / 89 | 58% | 110.70 | 526 / 901 |
adrenal gland | 100% | 6128.45 | 257 / 258 | 53% | 177.25 | 122 / 230 |
intestine | 78% | 4359.88 | 751 / 966 | 68% | 130.29 | 358 / 527 |
skin | 92% | 8265.81 | 1671 / 1809 | 53% | 80.72 | 248 / 472 |
esophagus | 69% | 2246.43 | 1003 / 1445 | 71% | 147.99 | 130 / 183 |
ovary | 42% | 1043.62 | 75 / 180 | 80% | 253.88 | 346 / 430 |
uterus | 52% | 1371.83 | 89 / 170 | 64% | 146.36 | 295 / 459 |
bladder | 67% | 1564.71 | 14 / 21 | 49% | 91.41 | 246 / 504 |
adipose | 92% | 9188.44 | 1111 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 88% | 4543.64 | 1169 / 1335 | 0% | 0 | 0 / 0 |
muscle | 66% | 3747.86 | 532 / 803 | 0% | 0 | 0 / 0 |
heart | 56% | 1391.63 | 483 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 52% | 52.60 | 15 / 29 |
tonsil | 0% | 0 | 0 / 0 | 42% | 71.15 | 19 / 45 |
eye | 0% | 0 | 0 / 0 | 38% | 27.35 | 30 / 80 |
spleen | 13% | 210.61 | 32 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 3% | 146.16 | 27 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071294 | Biological process | cellular response to zinc ion |
GO_0071276 | Biological process | cellular response to cadmium ion |
GO_0071280 | Biological process | cellular response to copper ion |
GO_0010273 | Biological process | detoxification of copper ion |
GO_0045926 | Biological process | negative regulation of growth |
GO_0006882 | Biological process | intracellular zinc ion homeostasis |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | MT1E |
Protein name | Metallothionein Metallothionein-1E (MT-1E) (Metallothionein-IE) (MT-IE) |
Synonyms | |
Description | FUNCTION: Metallothioneins have a high content of cysteine residues that bind various heavy metals; these proteins are transcriptionally regulated by both heavy metals and glucocorticoids. FUNCTION: Metallothioneins have a high content of cysteine residues that bind various heavy metals. . |
Accessions | ENST00000330439.7 [P04732-2] ENST00000306061.10 [P04732-1] H3BU80 ENST00000568293.1 P04732 |